Old Web
English
Sign In
Acemap
>
authorDetail
>
David Poticha
David Poticha
University of Colorado Denver
Virology
Lamivudine
Zidovudine
Drug resistance
Virus
4
Papers
212
Citations
0.02
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Intellectual Property ‐ The Foundation of Innovation
2019
Journal of Mass Spectrometry
David Poticha
Mark W. Duncan
Show All
Source
Cite
Save
Citations (1)
Inhibition of Purified Recombinant Reverse Transcriptase from Wild-Type and Zidovudine-Resistant Clinical Isolates of Human Immunodeficiency Virus Type 1 by Zidovudine, Stavudine, and Lamivudine Triphosphates
2001
The Journal of Infectious Diseases
Chengying Duan
David Poticha
Thomas C. Stoeckli
Christos J. Petropoulos
Jeannette M. Whitcomb
Charles S. McHenry
Daniel R. Kuritzkes
Show All
Source
Cite
Save
Citations (10)
emergence of Dual Resistance to Zidovudine and Lamivudine in Hiv-1-infected Patients Treated With Zidovudine Plus Lamivudine as Initial Therapy
2000
Journal of Acquired Immune Deficiency Syndromes
Daniel R. Kuritzkes
David Shugarts
Minoo Bakhtiari
David Poticha
Judy Johnson
Marc Rubin
Thomas R. Gingeras
Mitchell Kennedy
Joseph J. Eron
Show All
Source
Cite
Save
Citations (39)
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.
1996
AIDS
Daniel R. Kuritzkes
Joseph B. Quinn
Sharon L. Benoit
David Shugarts
Aaron Griffin
Minoo Bakhtiari
David Poticha
Joseph J. Eron
Mary Ann Fallon
Marc Rubin
Show All
Source
Cite
Save
Citations (162)
1
map